Core Viewpoint - Syra Health Corp. will announce its financial results for the fourth quarter and full year of 2025 on March 12, 2026, highlighting its focus on improving health outcomes through accessible and affordable healthcare solutions [1] Company Overview - Syra Health is an integrated healthcare solutions company that serves government and commercial healthcare organizations [1] - The company specializes in healthcare prevention, expanding access, and delivering affordable solutions [1] - Syra Health utilizes healthcare analytics to provide proactive insights and data-driven intelligence [1] - The company offers HIPAA-compliant digital health solutions that enable measurable health outcomes in regulated environments [1] - Through training and education, Syra Health aims to help healthcare organizations reduce costs and deliver high-quality care [1]

Core Insights - Syra Health Corp. reported a decline in revenue for Q3 2025, primarily due to federal spending cuts impacting state and county government budgets, with revenue falling to $1.7 million from $2.3 million in Q3 2024 [5][7] - The Population Health business unit experienced significant growth of 96% year-over-year, indicating strong market demand for its solutions [3][8] - The company improved its gross margin by 300 basis points to 33% and reduced its net loss by 46% through cost management and operational efficiency [3][7] Financial Performance - Q3 2025 revenue was $1.7 million, down from $2.3 million in Q3 2024, largely due to federal budget cuts [5][14] - Population Health segment revenue reached $1,280,011, up from $652,298 in Q3 2024, driven by upselling to state health departments and private sector customers [8][14] - Gross margin improved to 33% in Q3 2025 from 30% in Q3 2024, attributed to a strategic focus on higher-margin business units [8][14] - Net loss decreased to ($225,902) in Q3 2025 from ($417,535) in Q3 2024, reflecting improved operational efficiency [7][14] Cost Management - Total operating expenses for Q3 2025 were $786,712, a 28% decline from $1,097,208 in the previous year, due to disciplined cost management [9][14] - Salaries and benefits decreased by 43% to $336,390, resulting from workforce optimization efforts [9][14] - Selling, general, and administrative expenses fell by 12% to $252,384 as part of overhead reduction initiatives [11][14] Strategic Focus - The company is refining its strategy to concentrate on its successful Population Health solutions, which is contributing to growth in its sales pipeline [4][5] - Syra Health's focus on targeted upselling and expansion into the private sector is expected to enhance its market position as federal budget clarity improves [4][5] Cash Position - As of September 30, 2025, Syra Health had cash and cash equivalents of $2.0 million and no long-term debt [11][12] - The company continues to manage its cash flow effectively, with a net cash used in operating activities of ($158,554) for the quarter [15]

Core Insights - Syra Health Corp. will report its financial results for the three months ended September 30, 2025, on November 12, 2025, before market opening [1]. Company Overview - Syra Health is a healthcare solutions company that serves both public and private healthcare organizations, focusing on innovative solutions that positively impact entire populations [2]. - The company specializes in healthcare prevention, expanding access, and delivering affordable solutions, with capabilities in healthcare analytics that provide proactive, actionable insights [2]. - Syra Health's digital health solutions are HIPAA-compliant and fully accessible, enabling measurable health outcomes in regulated healthcare environments [2]. - The company also emphasizes training and education to help healthcare organizations reduce costs and deliver consistent, high-quality care [2].